Evaluation of the Impact of Embryo Biopsy on the Reproductive Potential of Embryos Undergoing In Vitro Fertilization (IVF)
Sponsored by Reproductive Medicine Associates of New Jersey
About this trial
Last updated 12 years ago
Study ID
Status
Type
Placebo
Accepting
Trial Timing
Ended 13 years ago
What is this trial about?
What are the participation requirements?
Inclusion Criteria
This study will recruit patients from the NY/NJ/CT/eastern PA area only. 1. Maximum of one prior failed IVF treatment cycle 2. Female partner less than 35 years of age 3. Normal day 3 FSH level (<10 miu/mL) 4. Total basal antral follicle count greater than or equal to 12 5. Male partner with greater than 100,000 total motile spermatozoa and at least 1% normal forms 6. Body mass index (BMI) < or = 32 7. Normal uterine cavity
Exclusion Criteria
1. Diagnosis of chronic anovulation secondary to polycystic ovarian disease 2. Diagnosis of endometrial insufficiency 3. Clinical indication for pre-implantation genetic diagnosis (PGD) (undergoing IVF with PGD to rule out a known genetic defect) 4. Use of testicular aspiration or biopsy procedures to obtain sperm